L&C Bio (L&C Bio Co., Ltd) Completes Acquisition of L&C China for MegaDerm Plus NMPA Approval

LianMedical Completes Merger Between LianBio and LianMedical

July 17, 2026

Medical Devices

LianMedical (formerly LianBio) announced the completion of its previously announced merger between LianBio and LianMedical. Under the approved plan of merger, LianMedical merged with and into LianBio, and LianBio continued as the surviving company, with the company changing its name to LianMedical effective upon completion.

Vector Science & Therapeutics Options Up to 15% of LyoGenesis Plus to Gain Access to MPP’s cGMP Manufacturing Facility

May 13, 2026

Healthcare Services

Vector Science & Therapeutics entered into an option agreement to purchase up to a 15% equity interest in LyoGenesis Plus for cash payments of up to US$1.0 million over three years. Through LyoGenesis Plus’s planned acquisition of MPP Group LLC, Vector would secure long-term access to an FDA-registered, cGMP-compliant contract development and manufacturing organization based in Mequon, Wisconsin.

BioCina and NovaCina Announce Strategic Merger to Create Integrated CDMO

January 13, 2025

Healthcare Services

BioCina and NovaCina announced a strategic merger that will create a fully integrated, end-to-end contract development and manufacturing organization (CDMO) under the BioCina name. The combined offering spans cell line and process development through clinical and commercial drug substance manufacturing and sterile fill-finish, leveraging BioCina’s Adelaide capabilities and NovaCina’s Perth sterile fill-finish plant.

Mitsui & Co. Acquires Dermaceutical Laboratories (D-LAB)

August 21, 2023

Consumer Products

Mitsui & Co., Ltd. has agreed to acquire all shares of Dermaceutical Laboratories, LLC (D-LAB), a Bergen County, New Jersey-based cosmetics ODM and contract manufacturer. Mitsui will position D-LAB as the core beauty & personal care (BPC) business in the Americas, leveraging Japanese technologies and Mitsui's procurement and global network to expand capabilities and scale in the U.S. market.

Mountaingate Capital Acquires BioDerm

January 11, 2021

Medical Devices

Denver-based private equity firm Mountaingate Capital has acquired BioDerm, Inc., a Largo, Florida manufacturer of disposable medical devices and wound care supplies, in a transaction supported by subordinated debt and an equity co-investment from Five Points Capital and additional financing from Abacus Finance Group. Mountaingate said it will accelerate BioDerm's organic growth and pursue add-on acquisitions to expand product and service offerings while management and founder shareholders retain a continued ownership/board role.

Lonza AG Acquires PharmaCell BV

June 1, 2017

Biotechnology

Lonza AG has completed the acquisition of PharmaCell BV, a leading European contract manufacturer of cell and gene therapies with facilities in Maastricht and Sittard-Geleen. The deal expands Lonza's autologous cell-therapy manufacturing capabilities in Europe and integrates PharmaCell's GMP production capacity and experienced team into Lonza's global CDMO network.